Hudson Institute - Department of Molecular and Translational Science

PACIFIC-Real World: First real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (D4194R00005)

Markman, B. & Baker, E.

17/10/19 → 31/12/24

Project: Research

Children’s Brain Cancer Clinical Trial Program

Gottardo, N., Strong, R. & Jones, J.

Foundation for Children (FFC)

1/10/19 → 30/09/24

Project: Research

Pilot Study of Nivolumab in Pediatric Patients with Hypermutant Cancers

Ziegler, D. & Strong, R.

Cure Brain Cancer Foundation

1/10/19 → 30/09/22

Project: Research

Novel bacteria as therapeutic candidates in Inflammatory Bowel Disease

Giles, E., Forster, S. & Abud, H.

1/10/19 → 30/09/20

Project: Research

A Phase 1a/1b Multicentre, Open label, Dose escalation and Dose expansion Study to Evaluate the Safety, Pharmacokinetics, And Antitumor Activity of Ak104 in Subjects with Advanced Solid Tumours

Markman, B.

20/09/19 → 19/09/24

Project: Research

Predicting response to lenalidomide based induction: Real World Experience

Grigoriadis, G.

Celgene Pty Ltd

12/09/19 → 28/02/23

Project: Research

Improving Fracture Prediction and Clinical Care for Patients with Chronic Kidney Disease and Kidney Transplantation’.

Aleksova, J., Elder, G. J., Ebeling, P. & Milat, F.

4/09/19 → 3/03/20

Project: Research

Investigating the roles of non-coding RNAs in inflammatory signalling and cancer

Conos, S. & Lawlor, K.

5/08/19 → 28/02/22

Project: Research

Endometriosis susceptibility genes in endometrial stem/progenitor cells

Gargett, C., Montgomery, G. & Rombauts, L.

United States Department of Defense (DoD)

1/08/19 → 31/07/22

Project: Research

TTOCLC: Therapeutic Targeting of the Leader Cell population in Ovarian Cancer

Bilandzic, M. & Stephens, A.

1/07/19 → 30/06/22

Project: Research

Children's Brain Cancer Research - CB4BC Grant

Gottardo, N. & Strong, R.

Carrie Bickmore's Beanies 4 Brain Cancer Foundation

1/07/19 → 30/06/24

Project: Research

Precision Medicine for hypertension: Early detection of primary aldosteronism

Yang, J., Fuller, P., Young, M., Stowasser, M., Russell, G., Bach, L., Gilfillan, C., Lu, Z. X., Reid, C., Chen, G. & Gwini, S.

1/07/19 → 30/06/21

Project: Research

Bacterial communities in metropolitan, rural and indigenous Australians

Forster, S. & Gibney, K. B.

12/06/19 → 11/06/23

Project: Research

A Phase la/lb, Open-Label, Multiple-Dose, Dose-Escalation and Expansion Study of the Anti-PD-1 Monoclonal Antibody CS1003 in Subjects with Advanced Solid Tumors

Markman, B.

6/06/19 → 5/06/24

Project: Research

An Open-Label, Randomized, Phase 3 Trial of Nivolumab, or Nivolumab plus Ipilimumab, versus platinum doublet chemotherapy in Subjects with Chemotherapy-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC) study

Markman, B.

3/06/19 → 2/06/24

Project: Research

Bazedoxifene – A New Selective Estrogen Receptor Modulator Treatment for People with Schizophrenia

Kulkarni, J., Gurvich, C., Thomas, N., Sundram, S., Hill, R. & Chu, S.

1/06/19 → 31/05/22

Project: Research

A Phase 1b Study of Talimogene Laherparepvec in Combination With Atezolizumab in Subjects with Triple Negative Breast Cancer and Colorectal Cancer with Liver Metastases

Markman, B.

20/05/19 → 19/05/24

Project: Research

A Phase 1a/1b Study of FPA150, an Anti-B7-H4 Antibody, in Patients with Advanced Solid Tumors

Markman, B.

30/04/19 → 29/04/24

Project: Research

The PARC study: A phase I/II study evaluating the safety and activity of Pegylated recombinant human Arginase (BCT-100) Relapsed/refractory Cancers of Children and Young Adults

Kirby, M. L., McCowage, G., Ziegler, D., Mussai, F., Strong, R. & Jones, J.

Department of Health (Comm)

2/04/19 → 31/12/22

Project: Research

SIOPEN : SIOPEN neuroblastoma clinical trials in Australia and New Zealand

Strong, R., Trahair, T. & Jones, J.

Children's Cancer Foundation

1/04/19 → 31/03/24

Project: Research

COZMOS: Phase I/Ib trial of combined 5'azacitidine and carboplatin for recurrent/refractory pediatric brain and solid tumors

Hansford, J. R., Kellie, S., Valvi, S., Ramaswamy, V., Jones, J. & Strong, R.

Carrie Bickmore's Beanies 4 Brain Cancer Foundation, Department of Health (Comm)

1/04/19 → 31/03/22

Project: Research

Phase I evaluation of LY2606368 for children and adolescents with refractory or recurrent medulloblastoma brain tumours

Gottardo, N., Robinson, G. W., Gajjar, A., Pfister, S. M., Witt, O., Endersby, R., Stewart, C. F., Jones, J. & Strong, R.

Carrie Bickmore's Beanies 4 Brain Cancer Foundation, Department of Health (Comm)

1/04/19 → 31/03/24

Project: Research

A Phase 1b, Open-Label, Multiple Dose, Dose Escalation and Expansion Study to Investigate the Safety , Pharmacokinetics and Antitumor Activity of the Anti-PD-1 Monoclonal Antibody BGB-A317 in Combination with the PARP Inhibitor BGB-290 in Subjects with Advanced Solid Tumors

Markman, B.

25/03/19 → 24/03/24

Project: Research

Modulation Of the Tumour Microenvironment Using Either Vascular Disrupting Agents or STAT3 Inhibition in Order to Synergise with PD1 Inhibition in Microsatellite Stable, Refractory Colorectal Cancer

Markman, B.

8/03/19 → 7/03/24

Project: Research

A Phase 1, Open-Label, Multicenter, Dose-Escalation Study to Evaluate the Safety and Tolerability of SHR-1316 in Subjects with Advanced Solid Tumors

Markman, B.

28/02/19 → 27/02/24

Project: Research

Primary Aldosteronism: Prevalence, Clinical Features, and Biomarkers

Libianto, R. & Fuller, P.

Heart Foundation

18/02/19 → 17/02/22

Project: Research

Primary Aldosteronism: Prevalence, Clinical Features, and Biomarkers

Libianto, R. & Fuller, P.

18/02/19 → 17/02/22

Project: Research

Using next generation sequencing technology to improve the diagnosis of pancreatic cancer

Croagh, D., Southey, M., Jenkins, B., Segelov, E., Rathi, V., Holt, B. A., Pilgrim, C., Bhutani, M. & Tagkalidis, P.

Victorian Cancer Agency

15/02/19 → 14/02/23

Project: Research

A Phase 1/1b Multicenter Study to Evaluate the Humanized Anti-CD 73 Antibody, CP-I006, As A Single Agent, In Combination With CPI-444, And In Combination With Pembrolizumab In Adult Subjects With Advanced Cancers

Markman, B.

12/02/19 → 11/02/24

Project: Other

Project 220: My Room Clinical Research Fellowship

Cain, J., Firestein, R. & Downie, P.

1/02/19 → 31/01/22

Project: Research

A Phase 1/2a Study of BMS-986205 Administered in Combination with Nivolumab (BMS-936558, anti-PD-1 Monoclonal Antibody) in Advanced Cancers

Markman, B.

29/01/19 → 28/01/24

Project: Research

A Phase II Clinical Trial Evaluating Ipilimumab & Nivolumab in Combination for the Treatment of Rare Gastrointestinal, Neuro-Endocrine and Gynaecological Cancers

Markman, B.

11/01/19 → 10/01/24

Project: Research

Targeting key regulators of innate immunity in inflammation-associated cancer

Jenkins, B.

1/01/19 → 31/12/23

Project: Research

Frontline and Relapse study in RhabdoMyoSarcoma

Campbell, M., Sullivan, M., Hong, A., Lewin, J., Trahair, T., Jenney, M., Jones, J. & Strong, R.

Department of Health (Comm)

1/01/19 → 31/12/23

Project: Research

Understanding immune disorders of the gut

Pearson, J.

National Health & Medical Research Council (NHMRC)

1/01/19 → 31/03/23

Project: Research

Optimizing neonatal resuscitation in the delivery room

Hooper, S.

1/01/19 → 31/12/23

Project: Research

Validation of a Prognostic Assay for Embryo Transfer Outcome

Edgell, T., Salamonsen, L., Rombauts, L. & Vollenhoven, B.

National Health & Medical Research Council (NHMRC)

1/01/19 → 31/12/20

Project: Research

Unravelling the role of type I Interferon family in human infectious and inflammatory diseases

Hertzog, P., Casanova, J., Netea, M. G., Turner, S., Creek, D., Gearing, J., Croft, N., Forster, S. & Polo, J.

National Health & Medical Research Council (NHMRC)

1/01/19 → 31/12/23

Project: Research

Phenotypic, genomic and informatic characterization of host-microbiota interactions to improve human health

Forster, S.

National Health & Medical Research Council (NHMRC)

1/01/19 → 31/12/22

Project: Research

Preventing inflammation-induced brain injury in preterm infants: targeting systemic tumour necrosis factor

Galinsky, R., Gunn, A. J., Polglase, G., Dean, J. M. & Miller, S.

1/01/19 → 31/12/22

Project: Research

Cells and nanobiomaterials to treat and prevent Pelvic Organ Prolapse

Gargett, C., Mukherjee, S., Brosens, J. J., Werkmeister, J. A., Rosamilia, A., Deane, J., Ott, S., Arkwright, J. W. & Weiss, A. S.

1/01/19 → 31/12/22

Project: Research

Role of programmed cell death in NLRP3 inflammasome activation and Metabolic Syndrome

Lawlor, K.

1/01/19 → 31/12/21

Project: Research

Characterisation of mobile antimicrobial resistance in the human gastrointestinal microbiota

Forster, S., Costello, S. & Lawley, T. D.

National Health & Medical Research Council (NHMRC)

1/01/19 → 31/12/22

Project: Research

Optimising neurodevelopmental outcomes for fetal growth restriction

Miller, S., Jenkin, G., Malhotra, A. & Allison, B.

National Health & Medical Research Council (NHMRC)

1/01/19 → 31/12/22

Project: Research

Improving breathing of preterm newborns exposed to inflammation during pregnancy

Stojanovska, V.

1/01/19 → 31/12/22

Project: Research

Molecular Genetics of Human Sexual Differentiation

Harley, V.

1/01/19 → 31/12/23

Project: Research

Increasing Accessibility of Regenerative Medicine Through Innovative Solutions

Lim, R.

1/01/19 → 31/12/22

Project: Research

Phase 1/2 Study Investigating Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of AntiPDL1 Monoclonal Antibody BGBA333 Alone and in Combination with AntiPD1 Monoclonal Antibody BGBA317 in Patients with Advanced Solid Tumors

Markman, B.

20/12/18 → 19/12/23

Project: Research

A Phase I/II Trial of the combination of BRAF and EGFR inhibition in BRAF V600E mutant metastatic colorectal, advanced or metastatic lung adenocarcinoma and other cancers

Markman, B.

20/12/18 → 19/12/23

Project: Research

A Phase 1, Open Label, Multiple Dose, Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics and Antitumor Activities of the anti-PD-1 Monoclonal Antibody BGB-A317 in Subjects with Advanced Tumors

Markman, B.

20/12/18 → 19/12/23

Project: Research